© 2019 bioProtonics, Inc. 

MR µTexture

A new era in diagnostics

TM

bioProtonics' MR-based diagnostic µTexture enables a fast, non-invasive, in vivo measure of the fine changes in biologic tissue that are the earliest indicators of disease onset, and the most sensitive measure of disease progression.  This powerful new diagnostic has the potential to be a game changer in both disease treatment and in drug discovery, across a range of debilitating diseases.    
  • Clinically robust—works in the real world

  • Fits seamlessly into MRI radiology workflow

  • One minute added sequence—low cost

  • Software implementation—no expensive hardware 

  • Readily operable by any scan technician

  • Non-invasive—can be repeated as often as desired

  • Non-invasive—can be used to characterize entire organ, eliminating sampling errors